Select a year:

4 questions au professeur Guillaume Canaud

 En tant que scientifique, associez-vous un ou des objectifs spécifiques à votre activité de recherche ? Si oui lequel ou lesquels ? Pr. Canaud: Oui effectivement, je me pose, ou plutôt nous nous posons car il s’agit d’un travail d’équipe, deux questions clés :  1-Comment cela fonctionne-t-il ?  2-Comment utiliser nos connaissances pour améliorer la vie des&hellip

Read More

4P-Pharma and Delta 4 join forces to find and develop treatments for a rare autoimmune chronic liver disease

4P-Pharma and Delta 4, an Austrian digital drug development company, today announce the signing of a collaboration agreement. Under this agreement, both companies will jointly identify and develop first-in-class drug candidates for a rare autoimmune chronic liver disease for which currently no effective curative treatment is available.​ Kurt Herpel, CEO of Delta4 commented that “We are looking forward to&hellip

Read More

4P-Pharma at BIO 2022

4P-Pharma will attend the upcoming BIO2022, in San Diego (US), June 13-16.​ Revital Rattenbach, our chairwoman, Roselina Lam, our business development and licensing-in manager are glad to attend the event, as part of the Business France delegation.​ To learn more about us, our pipeline and discuss future partnership, please feel free to connect with us via the partnering platform or by e-mail.​​ We are&hellip

Read More

4P-Pharma at upcoming ALS Drug Development 2022​

4P-Pharma will attend the upcoming ALS Drug Development 2022 starting next week, May 24-26 in Boston (US).​ Célia Rabhi, our PhD student working on our 4P019 project on neurodegenerative diseases, will attend it.​ To learn more about us, please feel free to connect with us.​ For further information on the event, click here.

Read More

4P-Pharma at ARVO 2022

The ARVO annual meeting organized by the Association for Research in Vision and Ophthalmology starts next week, from 2022 May 1st-4th in Denver (USA).​ We are glad to announce the participation of Lola Vigouroux Sautet, our junior Project Manager of 4P020, our dry AMD  To learn more about us and 4P020, please feel free to connect with us. She is looking forward&hellip

Read More

4P-Pharma at BIO Europe Spring 2022

4P-Pharma is present at BIO Europe Spring 2022! ​Join us at the digital event. Roselina Lam, our Business Development and Licensing–in Manager, will attend the upcoming BIO Europe Spring on 2022, March 28th-31st delivered digitally.​ To learn more about us, our pipeline and discuss future partnership, please feel free to connect with us via the partnering platform  or by e-mail.​ She is looking forward&hellip

Read More